Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI

Psychiatry Research - Neuroimaging

Volumn 233, Issue 2, 2015, Pages 120-124

  Ide, Satoru ^a   Kakeda, Shingo ^a   Watanabe, Keita ^a   Yoshimura, Reiji ^a   Abe, Osamu ^b   Hayashi, Kenji ^a   Ueda, Issei ^a   Kishi, Taro ^c   Katsuki, Asuka ^a   Umene Nakano, Wakako ^a   Iwata, Nakao ^c   Nakamura, Jun ^a   Korogi, Yukunori ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Major depressive disorder; Prefrontal cortex; Val66Met polymorphism of BDNF gene; Voxel based morphometry

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE FRONTAL GYRUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; VOXEL BASED MORPHOMETRY; ATROPHY; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ATROPHY; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX;

EID: 84938744121     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2015.05.016     Document Type: Article

References (43)

1. Ashburner J. Computational anatomy with the SPM software. Magn. Reson. Imaging 2009, 27:1163-1174.
2. Ashburner J., Friston K.J. Voxel-based morphometry--the methods. Neuroimage 2000, 11:805-821.
3. Bath K.G., Lee F.S. Variant BDNF (Val66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci. 2006, 6:79-85.
4. Benjamin S., McQuoid D.R., Potter G.G., Payne M.E., MacFall J.R., Steffens D.C., Taylor W.D. The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. Am. J. Geriatr. Psychiatry 2010, 18:323-331.
5. Bora E., Fornito A., Pantelis C., Yücel M. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J. Affect. Disord. 2012, 138:9-18.
6. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 2006, 59:812-815.
7. Carballedo A., Morris D., Zill P., Fahey C., Reinhold E., Meisenzahl E., Bondy B., Gill M., Möller H.J., Frodl T. Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 2013, 162:183-190.
8. Cardoner N., Soria V., Gratacòs M., Hernández-Ribas R., Pujol J., López-Solà M., Deus J., Urretavizcaya M., Estivill X., Menchón J.M. Val66met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome. Depress. Anxiety 2013, 30:225-233.
9. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 2004, 24:4401-4411.
10. Cole J., Weinberger D., Mattay V., Cheng X., Toga A., Thompson P., Powell-Smith G., Cohen-Woods S., Simmons A., McGuffin P. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav. 2011, 10:756-764.
11. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
12. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
13. First M., Gibbon M., Spitzer R., Williams J., Benjamin L. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II): Interview and Questionnaire 1997, APA, Washington, DC.
14. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Non-patient Edition (SCID-I/NP, Version 2.0-8/98 revision). Biometrics Research Department 1997, New York State Psychiatric Instiute, New York, NY.
15. Frodl T., Schüle C., Schmitt G., Born C., Baghai T., Zill P., Bottlender R., Rupprecht R., Bondy B., Reiser M. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 2007, 64:410-416.
16. Gonul A.S., Kitis O., Eker M.C., Eker O.D., Ozan E., Coburn K. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. World J. Biol. Psychiatry 2011, 12:110-118.
17. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
18. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003, 23:6690-6694.
19. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
20. Joffe R.T., Gatt J.M., Kemp A.H., Grieve S., Dobson-Stone C., Kuan S.A., Schofield P.R., Gordon E., Williams L.M. Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: implications for depressive illness. Hum. Brain Mapp. 2009, 30:1246-1256.
21. Jovicich J., Czanner S., Greve D., Haley E., van der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., Macfall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006, 30:436-443.
22. Kanellopoulos D., Gunning F.M., Morimoto S.S., Hoptman M.J., Murphy C.F., Kelly R.E., Glatt C., Lim K.O., Alexopoulos G.S. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am. J. Geriatr. Psychiatry 2011, 19:13-22.
23. Karege F., Schwald M., El Kouaissi R. Drug-induced decrease of protein kinase a activity reveals alteration in BDNF expression of bipolar affective disorder. Neuropsychopharmacology 2004, 29:805-812.
24. Koolschijn P., van Haren N.E., Lensvelt-Mulders G.J., Pol H., Hilleke E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 2009, 30:3719-3735.
25. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000, 10:120-131.
26. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
27. Machado-Vieira R., Dietrich M.O., Leke R., Cereser V.H., Zanatto V., Kapczinski F., Souza D.O., Portela L.V., Gentil V. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol. Psychiatry 2007, 61:142-144.
28. Maldjian J.A., Laurienti P.J., Burdette J.H. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004, 21:450-455.
29. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
30. Matsuo K., Walss-Bass C., Nery F.G., Nicoletti M.A., Hatch J.P., Frey B.N., Monkul E.S., Zunta-Soares G.B., Bowden C.L., Escamilla M.A., Soares J.C. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 2009, 34:1904-1913.
31. Molendijk M., Van Tol M., Penninx B., Van Der Wee N., Aleman A., Veltman D., Spinhoven P., Elzinga B. BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity. Transl. Psychiatry 2012, 2:e74.
32. Molendijk M.L., Spinhoven P., Polak M., Bus B.A., Penninx B.W., Elzinga B.M. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol. Psychiatry 2014, 19(7):791-800.
33. Nemoto K., Ohnishi T., Mori T., Moriguchi Y., Hashimoto R., Asada T., Kunugi H. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci. Lett. 2006, 397:25-29.
34. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 2004, 24:10099-10102.
35. Salvadore G., Nugent A.C., Lemaitre H., Luckenbaugh D.A., Tinsley R., Cannon D.M., Neumeister A., Zarate C.A., Drevets W.C. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage 2011, 54:2643-2651.
36. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003, 54:70-75.
37. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., Craddock N., DePaulo J.R., Lander E.S. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry 2002, 7:579-593.
38. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
39. Soares J.C., Mann J.J. The anatomy of mood disorders--review of structural neuroimaging studies. Biol. Psychiatry 1997, 41:86-106.
40. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J. Psychiatr. Res. 1997, 31:393-432.
41. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
42. Vigers A.J., Baquet Z.C., Jones K.R. Expression of neurotrophin-3 in the mouse forebrain: insights from a targeted LacZ reporter. J. Comp. Neurol. 2000, 416:398-415.
43. Yan Q., Rosenfeld R.D., Matheson C.R., Hawkins N., Lopez O.T., Bennett L., Welcher A.A. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 1997, 78:431-448.